NewsRoom Articles - Page 161 of 219

TuesdayJun 15, 2021 9:15 am

Brain Scientific Inc. (BRSF) Tech to be Used in a Ketamine Clinical Study for Mental Health Care

Ehave announced it will utilize BRSF's tech in an upcoming ketamine clinical study BRSF's tech will make it possible to correlate biomarkers for the identification of chronic pain, depression, PTSD, bipolar disorder, and more. The data from this clinical trial has the potential to provide longitudinal insights that can link brain analysis and psychedelics Brain Scientific (OTCQB: BRSF), a commercial-stage health care company, is on a mission to modernize brain diagnostics with cutting-edge tech that bridges the widening gap in access to quality care. The company's technology will be part of a ketamine clinical study conducted by Ehave, Inc. (OTC:…

MondayJun 14, 2021 3:10 pm

Study Discovers That Major Depressive Disorder Increases Healthcare Burden

According to recently released research, patients who suffer from inflammatory bowel disease and major depressive disorder have higher healthcare burdens and discharge rates, as well as increased morbidity. Major depressive disorder, which is sometimes referred to as clinical depression, affects an individual’s behavior and mood as well as physical functions such as sleep and appetite. This disorder is a common mental health condition in the United States, with data suggesting that more than 7% of adults in the country experience depressive episodes. On the other hand, inflammatory bowel disease represents various intestinal ailments that bring about prolonged inflammation of an…

MondayJun 14, 2021 9:58 am

DGE’s 2nd Medical Writing Innovation Strategies Conference for Life Sciences

Date: June 29-30, 2021Online Livestream Event Biopharma medical writing and communications professionals are invited are invited to attend DGE’s 2nd Medical Writing Innovation Strategies Conference for Life Sciences live streaming on June 29-30, 2021. The event will offer useful tips and guide medical professionals to learn innovative skills for filtering technical information that is effectively communicated for engagement. These power-packed sessions will assist medical writers and communicators in elevating their skills that will, in turn, boost their career growth. With the increasing pressure on medical writing, professionals will learn how to diffuse work stress and communicate harmoniously in the work…

MondayJun 14, 2021 9:00 am

Healthy Extracts Inc. (HYEX) Stands Distinct in the Development, Provision of Highest-Quality Supplements with Proven Health Benefits

HYEX’s portfolio of wholly owned subsidiaries currently comprises BergametNA and Ultimate Brain Nutrients BergametNA, whose products target cardiovascular and immune health, sources its formulations from the Citrus Bergamot SuperFruit(TM) The bergamot fruit is richly packed with polyphenolic flavanones, which are known to decrease bad cholesterol, triglyceride, and glucose, as well as increase the good cholesterol BergaMet only uses the highest concentration of polyphenolic flavanones (“BPF”) as the higher the BPF, the greater the effectiveness of the supplement Guided by the philosophy ‘Live Life Young Again’ and its commitment to superior health technology by engaging in the R&D of natural plant-based…

FridayJun 11, 2021 12:15 pm

Fibromyalgia and the Future of Telehealth

Fibromyalgia is an acute illness that can present as cognitive dysfunction, lack of energy, intense fatigue and abnormal pain among other symptoms. Sometimes, individuals who suffer from this condition may experience flares, when their symptoms get too intense. This makes it harder for them to perform simple tasks, even struggling to make it to doctor’s appointments. However, the coronavirus pandemic and improvements in technology have made it possible for fibromyalgia patients to access telehealth appointments, which allows them to talk with their doctor remotely, either via tablet, phone or computer, while they’re home. Patients can now schedule telehealth appointments with…

FridayJun 11, 2021 9:00 am

Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) to Sponsor Kernel Flow, Ketamine Feasibility Study

Feasibility study is designed to measure ketamine’s psychedelic effect on cerebral cortex hemodynamics Cybin, Kernel working together to leverage proprietary Kernel Flow device for psychedelic-based studies and clinical trials Ketamine is a dissociative injected anesthetic that blocks sensory perception Cybin (NEO: CYBN) (OTCQB: CLXPF) has announced a key step forward in its focus on progressing psychedelic therapeutics. The company will be sponsoring a feasibility study of the Kernel Flow technology; the study is designed to measure ketamine’s psychedelic effect on cerebral cortex hemodynamics (https://ibn.fm/BW1Jn). “We still have much to learn about what is occurring in the brain during a psychedelic…

FridayJun 11, 2021 9:00 am

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) on Course for Private Demonstrations of the i/Blue Imaging System(TM) at the American Urological Association Annual Conference in September

Further refinement of if the i/Blue Imaging System will incorporate changes intended to meet critical verification requirements established through benchmark testing of competitive systems as well as feedback from preliminary meetings with the FDA Bladder cancer is anticipated to cause over 1,000,000 physician consultations per year, resulting in $4 billion in total costs for bladder cancer treatment and management Imagin Medical plans to complete its proprietary i/Blue Imaging System in 2022 The National Cancer Institute (“NCI”) lists urinary bladder cancer as the sixth most prevalent form of cancer in the United States. In 2021, NCI estimates that the total number…

ThursdayJun 10, 2021 2:30 pm

Advancements in Imaging Techniques Allow Physicians to Better Manage Bladder Cancer

In the past few decades, there has been a considerable decline in the mortality rate related to bladder cancer. This, researchers speculate, may be associated with a reduction in smoking, advances in treatment and enhancements in bladder cancer diagnosis. Additionally, new therapies and more information about this disease have facilitated a change in this field, which allows health practitioners to have a better understanding of the ailment, thus saving more lives. However, bladder cancer is still among the most common cancers in the Unites States and also the most expensive, with regard to cancer care. The majority of diagnosed bladder…

ThursdayJun 10, 2021 10:46 am

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) to Present at H.C. Wainwright’s Upcoming Virtual Psychedelics Conference

Tryp Therapeutics’ Chairman and CEO Greg McKee will present at the virtual Psychedelics in Psychiatry and Beyond Conference planned for Thursday, June 17, 2021 As part of his presentation, McKee will discuss Tryp’s business and its pipeline, which includes its proprietary psilocybin-centered drug development program Tryp will present alongside other pharmaceutical companies leading research in psychedelic-assisted therapeutics Psychedelics have increasingly drawn the attention of different players and companies thanks to the research-driven revelations regarding their utility in treating a wide range of neuropsychiatric diseases. As a pharmaceutical company that has been furthering such research – specifically on psilocybin, a psychedelic…

ThursdayJun 10, 2021 10:06 am

United Medical Equipment Business Solutions Network Inc. May Offer Response to US Prescription Drugs Price Crisis; Provides GoodRx Functionality within its Medication Management App

Americans pay more for prescription drugs than any other nation in the world; prices keep increasing Patients pay about 14% of prescription drug costs out of pockets; around 20% report not being able to complete a prescribed course of medicine due to costs UME's committed to providing consumers better access to the healthcare they need; its Medication Management App features GoodRx in-built functionality enabling them to view discount prices and coupons United Medical Equipment Business Solutions Network ("UME") has developed the Medication Management App with twelve different functionalities within the convenience of one application, with the newest addition of GoodRX…

News and publishing service for medical and biotechnology related companies

Contact us: 512.354.7000

Brain Scientific Inc. (BRSF) Tech to be Used in a Ketamine Clinical Study for Mental Health Care

Study Discovers That Major Depressive Disorder Increases Healthcare Burden

DGE’s 2nd Medical Writing Innovation Strategies Conference for Life Sciences

Healthy Extracts Inc. (HYEX) Stands Distinct in the Development, Provision of Highest-Quality Supplements with Proven Health Benefits

Fibromyalgia and the Future of Telehealth

Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) to Sponsor Kernel Flow, Ketamine Feasibility Study

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) on Course for Private Demonstrations of the i/Blue Imaging System(TM) at the American Urological Association Annual Conference in September

Advancements in Imaging Techniques Allow Physicians to Better Manage Bladder Cancer

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) to Present at H.C. Wainwright’s Upcoming Virtual Psychedelics Conference

United Medical Equipment Business Solutions Network Inc. May Offer Response to US Prescription Drugs Price Crisis; Provides GoodRx Functionality within its Medication Management App

Official NewsWire Relationships

BioMedWire Currently Accepts

BioMedWire

Company Search

Site Search